BVS Stock: Bioventus Inc. Stock Price, Analysis & Insights
Get live BVS stock price $9.14, comprehensive Bioventus Inc. stock analysis, charts, news, and expert forecast. Real-time BVS stock data and investment insights.
Loading chart data...
Bioventus Inc. (BVS) Overview
Bioventus Inc. (BVS) is a publicly traded company in the Healthcare sector , specifically within the Medical - Devices industry . As of the latest trading session, BVS trades at $9.14 with a market capitalization of 619.05M . Over the past 52 weeks, BVS has traded between $5.81 and $11.25 , with the current price positioned at approximately 61% of this range . The stock currently trades at a pr...
Key Takeaways
- Operates in the Healthcare sector (Medical - Devices)
- Market cap: 619.05M
- Current price: $9.14
- 52-week range: $5.81 - $11.25
- P/E ratio: 22.29
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Bioventus Inc. is a global medical technology enterprise specializing in the development and market introduction of clinical solutions that activate and bolster the body's inherent regenerative processes. The company's diverse product range is catego...
Company Information
- CEO
- Robert E. Claypoole
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 930
Contact Information
- Website
- https://www.bioventus.com
- Address
- 4721 Emperor Boulevard
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 22.3)
✓ Lower volatility stock (Beta: 0.67) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Bioventus Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Bioventus Inc.
- ⚠Investors should consider how Bioventus Inc. fits within their overall portfolio allocation
Market Cap
619.05M
P/E Ratio (TTM)
22.29
Beta
0.67
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BVS with peer companies:
- Price
- $24.99
- Market cap
- 1.17B
- Price
- $5.44
- Market cap
- 1.42B
- Price
- $18.51
- Market cap
- 702.32M
- Price
- $4.08
- Market cap
- 526.76M
- Price
- $18.57
- Market cap
- 476.97M
- Price
- $0.87
- Market cap
- 338.80M
- Price
- $20.33
- Market cap
- 310.75M
- Price
- $42.98
- Market cap
- 614.51M
- Price
- $4.01
- Market cap
- 260.17M
- Price
- $10.64
- Market cap
- 447.94M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.